BACE1 and early-onset autosomal dominant Alzheimer disease: Compounds 1 and 25 moderately prohibited BACE1 (β-secretase 1), an enzyme involved in Alzheimer’s disease pathogenesis, however, the other metabolites had no or weak activity (Figure 4).